Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program

2020 ◽  
pp. 089719002094868
Author(s):  
Amy Frederick ◽  
Joyce Juan ◽  
Delaney Ivy ◽  
Yolanda Munoz Maldonado

Background: Pharmacists have a positive effect on clinical outcomes in chronic disease state management, however, few studies have evaluated the effect that frequency of visits may have on diabetes biomarkers such as hemoglobin A1c and blood pressure readings. Methods: Under the medication management program (MMP), patients with diabetes were seen monthly by pharmacists until early 2015, when time between visits was increased to every 3 months. A retrospective chart review was conducted to evaluate the primary outcome of the percent change in hemoglobin A1c and blood pressure after the change in visit frequency. Results: In the 303 patients enrolled, no statistical difference existed between the pre and post average A1c (p-value = 0.10). The intermediate average A1c was statistically lower from the preintervention mean A1c (p-value = 0.001) but not from the postintervention mean A1c (p-value = 0.30). No statistical differences were seen between systolic blood pressure and diastolic blood pressure. Conclusion: Patients who have been seen by a clinical pharmacist more frequently (every month or every other month) for several years may be able to maintain their reduction in A1c with less-frequent visits (every 3 to 6 months).

2011 ◽  
Vol 25 (2) ◽  
pp. 130-135 ◽  
Author(s):  
David R. Bright ◽  
Kelly R. Kroustos ◽  
Rhonda E. Thompson ◽  
Scott C. Swanson ◽  
Sara L. Terrell ◽  
...  

Objective: To describe the implementation and evaluation of a pilot multidisciplinary disease state management (DSM) program for diabetes, hypertension, and hyperlipidemia at a private, self-insured university (over 900 covered lives). Methods: Enrollees met with a pharmacist, nurse, exercise physiologist, and students in these disciplines to improve clinical outcomes and fitness parameters. Clinical values, quality of life, patient knowledge of disease states, and patient satisfaction were assessed. Results: Of the 20 patients in the pilot program, 17 completed 1 nursing and 2 pharmacist visits; 8 completed exercise physiology visits. At baseline, elevated blood pressure readings were observed in 64.7% (11 of 17) of patients, 20% of those with diabetes (1 of 5) had an elevated hemoglobin A1c value (HbA1c), and 82.4% (14 of 17) had a cholesterol value that was not at goal. At least 1 medication-related problem was observed in 16 patients (94.1%). At 3 months, all patients with diabetes achieved HbA1c levels at or below 7%, 4 patients attained blood pressure control, and 1 achieved normal cholesterol readings. Patients characterized participation in the program as valuable and convenient. Conclusions: Patients involved in the multidisciplinary DSM showed improved clinical outcomes after 3 months. Ongoing analysis of patient outcomes will determine the long-term effectiveness of the DSM.


Author(s):  
George R Marzouka ◽  
Elyse Julian ◽  
Andre Dias ◽  
Leonardo Tamariz ◽  
Pat Trahan ◽  
...  

Background: A significant correlation between hypertension (HTN) and long-term risk for heart failure (HF) exists. The aim of this study was (i) to assess what percent of patients enrolled in a heart failure disease management program (HFDMP) reach the JNC VII target goals for blood pressure control; (ii) to assess if there is a disparity in HTN control by race or ethnicity; (iii) and to assess the impact of reaching JNC VII targets for blood pressure control on survival. Methods: Patients with an ejection fraction ≤40% were enrolled into HFDMPs and screened for HTN, defined as blood pressure (BP) ≥ 130/80. Patients were titrated to beta blocker therapy and ace inhibitor therapy following the ACC/AHA HF guidelines. Final BP was measured after one year. Results: Mean baseline systolic BP (SBP) (N = 648) was 149.9 mmHg and mean baseline diastolic BP (DBP) was 90.5 mmHg. At one year, mean SBP decreased to 138.0 mmHg, DBP to 81.8 mmHg. There was no significant increase in survival for patients with BP ≤130 and ≤80 versus patients with HTN. There was a significant disparity in BP control in Blacks and Hispanics compared to whites (p<0.001) Conclusion: Disease management programs are an effective way to reduce BP in hypertensive patients, as well as keeping normotensive patients within JNC VII guidelines however health disparities persisted by race and ethnicity. Mean SBP and DBP of cohort at baseline Vs. 12 Month Follow up Blood pressure ≤ 130/80 mmHg Baseline Visit Last Visit P-Value SBP,m sd 110.9 (12.6%) 120.9 (22.2%) <0.001 DBP , m sd 67.1 (8.6%) 72.4 (13.7%) <0.001 Blood pressure > 130/80 mmHg Baseline Visit Last Visit P-Value SBP , m sd 149.9 (21.4%) 138.0 (24.6%) <0.001 DBP , m sd 90.5 (16.3%) 81.8 (16.8%) <0.001


Pharmacy ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 115
Author(s):  
Jarred Prudencio ◽  
Michelle Kim

Two clinical pharmacy faculty members from a college of pharmacy provide comprehensive medication management in a rural family medicine clinic. The data was assessed for patients with diabetes managed by the pharmacists from 1 January 2017 through to 31 December 2019 to determine the service’s impact on patient outcomes. The primary outcome of this study is the change in the goal attainment rates of the three clinical goals of hemoglobin A1c, blood pressure, and appropriate statin therapy after pharmacist intervention. A total of 207 patients were included. At baseline, the patients had an average of 1.13 of the three goals met, improving to an average of 2.02 goals met after pharmacist intervention (p < 0.001). At baseline, 4.8% of the patients had met all three clinical goals, improving to 30.9% after pharmacist intervention (p < 0.001). There were significant improvements for the individual goal attainment rates of hemoglobin A1c (24.15% vs. 51.21%, p < 0.001), blood pressure (42.51% vs. 85.51%, p < 0.001), and appropriate statin therapy (45.89% vs. 65.70%, p < 0.001). This data adds to the evidence supporting the integration of clinical pharmacists into primary care clinics to improve patient outcomes related to diabetes.


Author(s):  
Andi Ipaljri Saputra ◽  
Isramilda ,

Since 2014 BPJS Health has implemented the Chronic Disease Management Program (PROLANIS) which has a program of medical/educational consultation activities, home visits, reminders, club activities such as gymnastics and health status monitoring with the target of all BPJS health participants with chronic diseases (Diabetes Mellitus) Type 2 and Hypertension). The Batam Sehat Clinic conducted a chronic disease management program in 2015 with 154 registered patients, while BPJS patients who took part in the PROLANIS exercise in July-September 2018 totaled 155 people. This type of research is an observational analytic survey with a cross-sectional approach conducted at Batam Sehat Clinic. Data obtained by taking medical records in the form of attendance PROLANIS gymnastics with a total sampling technique that the overall number of BPJS patients who take PROLANIS exercises from July-September is 155 BPJS patients. From 155 BPJS patients, the frequency distribution of BPJS patients participating in PROLANIS and blood pressure was controlled 71 (85.5%) and uncontrolled blood pressure was 12 (14.5%). While those who did not participate in PROLANIS exercise were controlled blood pressure 32 (44.4%) and 40 (55.6%) uncontrolled blood pressure. Based on the results of statistical tests it is known that there is a correlation between the participation of PROLANIS gymnastics and blood pressure control in BPJS patients in Batam Sehat Clinic with p-value = 0,000 where p <0.05. Based on this research, it can be concluded that there is a correlation between the participation of PROLANIS gymnastics and the control of blood pressure in BPJS patients.


2006 ◽  
Vol 70 (3) ◽  
pp. 68 ◽  
Author(s):  
Susan J. Skledar ◽  
Teresa P. McKaveney ◽  
Charles O. Ward ◽  
Colleen M. Culley ◽  
Kelly C. Ervin ◽  
...  

Author(s):  
Harindra C Wijeysundera ◽  
Gina Trubiani ◽  
Xuesong Wang ◽  
Nicholas Mitsakakis ◽  
Peter Austin ◽  
...  

Background Multi-disciplinary heart failure (HF) clinics improve outcomes for HF patients in randomized clinical trials. It is unclear if this efficacy translates to real world effectiveness. Accordingly, our objectives were to 1) compare real world outcomes of HF patient treated in HF clinics vs that in standard care and 2) identify HF clinic features associated with improved outcomes. Methods The service components at all 34 HF clinics in Ontario, Canada were evaluated and scored using a validated instrument. Based these scores, the clinics were categorized by an expert panel into high/medium or low intensity strata. Our cohort consisted of all patients discharged alive after a HF hospitalization in 2006-07. Patients were classified as either HF clinic or standard care patients and followed until March 31st, 2010, to evaluate mortality, all-cause hospitalization, and HF hospitalization. Propensity score matching was used to compare outcomes between comparable groups of patients in the two groups, using Kaplan-Meier survival curves. We explored the clinic level characteristics associated with improved outcomes by developing marginal Cox-proportional hazard models, restricted to the overall sample of HF clinic patients, so as to account for clustering by HF clinic. Results We identified 14,468 HF patients, of whom 1,288 were seen in HF clinics. In a matched sample of 1,288 pairs, systematic differences between groups were substantially reduced. Over 3 years of follow-up, 52.1% of HF clinic patients died, compared to 54.7% of standard care patients (p-value 0.02). HF clinic patients had a significant increase in hospitalization (87.4% vs 86.6% for all-cause [p-value 0.009]; 58.7% vs 47.3% for HF-related [p-value <0.001]). Clinics in the high intensity strata were associated with lower mortality (hazard ratio [HR] 0.68 (95% confidence interval [CI] 0.48-0.98; p-value 0.04) but higher rates of all-cause hospitalization (HR 1.48; 95% CI 1.01-2.18; p-value 0.04) and HF hospitalization (HR 1.98; 95% CI 1.42-2.77; p-value <0.001), compared to low intensity clinics. HF clinics that targeted both the patient and caregiver were associated with improved survival compared to those that only focused on the patient, as were clinics with an emphasis on peer support. Clinics with frequent contacts between providers and patients had a significant reduction in mortality (HR 0.15; 95% CI 0.09-0.25; p-value <0.0001). A more intensive medication management program was associated with reduced all cause and HF hospitalization (HR 0.35 and HR 0.27 respectively). Conclusions Multi-disciplinary HF clinics are associated with a decrease in mortality but increase in re-hospitalizations compared to standard care. A gradient was observed between clinic intensity and outcomes whereby greater intensity of clinic services was associated with mortality reductions but increased hospitalization.


2018 ◽  
Vol 53 (1) ◽  
pp. 13-20 ◽  
Author(s):  
Jessica J. Tilton ◽  
Mansi G. Edakkunnathu ◽  
Kellyn M. Moran ◽  
Anna Markel Vaysman ◽  
Jessica L. DaPisa ◽  
...  

Background: Medication therapy management is widely promoted to improve care. However, few well-controlled studies have evaluated its impact. Objectives: We evaluated whether enrollment in a comprehensive medication therapy management clinic (MTMC) was associated with improved 12-month outcomes. Methods: This institutional review board approved study was a retrospective controlled cohort study in an academic health center serving low-income, African American and Latino populations. Between 2001 and 2011 MTMC patients were matched to control patients by age, gender, and comorbidities. Outcomes were mean change in glycosylated hemoglobin (A1C), diastolic (DBP) and systolic blood pressure (SBP), and emergency department (ED) and hospital admissions at 6 and 12 months. A difference-in-difference analysis was conducted for each outcome of interest, adjusting for observed, unmatched confounders. Results: Patients with diabetes and receiving MTMC had greater A1C improvements, compared with controls, of 0.54% (P = 0.0067) at 6 months and 0.63% (P = 0.0160) at 12 months. At 6 months, SBP and DBP decreased in MTMC patients by 6.5 mm Hg (P = 0.0108) and 3.8 mm Hg (P = 0.0136) more than controls, respectively. At 12 months, those receiving MTMC services had SBP and DBP decreases, respectively, of 8.2 mm Hg (P = 0.0018) and 1.7 mm Hg (P = 0.2691) compared with controls. ED and hospital visits were not statistically significantly different between groups. Conclusion and Relevance: This MTMC potentially improved outcomes for referred patients in whom target goals were difficult to achieve and can serve as a model for other similar medication management programs.


Sign in / Sign up

Export Citation Format

Share Document